4//SEC Filing
Carter Eric G 4
Accession 0001209191-18-026121
CIK 0001423824other
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 5:27 PM ET
Size
5.6 KB
Accession
0001209191-18-026121
Insider Transaction Report
Form 4
Carter Eric G
Interim Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-04-23+75,000→ 75,000 totalExercise: $13.65Exp: 2028-04-22→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]If the Reporting person remains continuously employed with the Issuer in good standing through the earlier to occur of (i) the twelve (12)-month anniversary of April 23, 2018 and (ii) the date that a new Chief Medical Officer begins employment with the Issuer (such earlier date, the "End Date"), 100% of the shares subject to the option will immediately vest on the End Date.
Documents
Issuer
ALDER BIOPHARMACEUTICALS INC
CIK 0001423824
Entity typeother
Related Parties
1- filerCIK 0001387660
Filing Metadata
- Form type
- 4
- Filed
- Apr 24, 8:00 PM ET
- Accepted
- Apr 25, 5:27 PM ET
- Size
- 5.6 KB